We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.36B
AUM Growth
-$521M
Cap. Flow
-$561M
Cap. Flow %
-16.68%
Top 10 Hldgs %
31.32%
Holding
2,193
New
694
Increased
377
Reduced
430
Closed
579
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPCOU
601
DELISTED
Golden Path Acquisition Corporation Units
GPCOU
$1.01M 0.03%
+100,000
New +$1.01M
BMY icon
602
CALL
Bristol-Myers Squibb
BMY
$132B
$1M 0.03%
17,800
JSPR icon
603
Jasper Therapeutics
JSPR
$23.6M
$1M 0.03%
10,100
UMPQ
604
DELISTED
Umpqua Holdings Corp
UMPQ
$1M 0.03%
+54,424
New +$1.01M
VGII.U
605
DELISTED
Virgin Group Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth
VGII.U
$1M 0.03%
100,072
+90,072
+901% +$903K
AVGO icon
606
PUT
Broadcom
AVGO
$2.04T
$1M 0.03%
21,000
FVIV.U
607
DELISTED
Fortress Value Acquisition Corp. IV Units, each consisting of one share of Class A common stock and one-eighth of one redeemable Warrant
FVIV.U
$1M 0.03%
100,000
-25,000
-20% -$250K
SCVX
608
DELISTED
SCVX Corp.
SCVX
$999K 0.03%
101,000
TNA icon
609
CALL
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.47B
$998K 0.03%
10,200
FLEX icon
610
Flex
FLEX
$44.8B
$995K 0.03%
73,871
+20,317
+38% +$276K
WDAY icon
611
Workday
WDAY
$44.4B
$993K 0.03%
4,160
+2,661
+178% +$640K
GLS
612
DELISTED
Gelesis Holdings, Inc.
GLS
$989K 0.03%
101,000
HUBG icon
613
HUB Group
HUBG
$2.92B
$984K 0.03%
29,824
-774
-3% -$26.4K
XOM icon
614
CALL
ExxonMobil
XOM
$634B
$984K 0.03%
18,500
-51,600
-74% -$3.08M
PLAN
615
DELISTED
Anaplan, Inc.
PLAN
$984K 0.03%
18,455
-7,257
-28% -$404K
WBD icon
616
Warner Bros
WBD
$67.1B
$983K 0.03%
32,080
-8,864
-22% -$307K
RFL icon
617
Rafael Holdings
RFL
$107M
$978K 0.03%
19,430
-5,842
-23% -$255K
ESTC icon
618
Elastic
ESTC
$7.81B
$976K 0.03%
+6,697
New +$837K
YUMC icon
619
Yum China
YUMC
$16.3B
$975K 0.03%
+14,712
New +$938K
RDY icon
620
Dr. Reddy's Laboratories
RDY
$10.2B
$970K 0.03%
66,000
KLAQ
621
DELISTED
KL Acquisition Corp Class A Common Stock
KLAQ
$970K 0.03%
+99,999
New +$975K
AAQC
622
DELISTED
Accelerate Acquisition Corp
AAQC
$969K 0.03%
+99,999
New +$970K
XOP icon
623
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.43B
$967K 0.03%
+10,000
New +$873K
FLY
624
DELISTED
Fly Leasing Limited
FLY
$956K 0.03%
+56,433
New +$954K
XYZ
625
PUT
Block Inc
XYZ
$47.5B
$951K 0.03%
3,900
-6,100
-61% -$1.41M

Similar funds

Prelude Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Prelude Capital Management held 2,193 positions worth $3.36B, down 13% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Prelude Capital Management withdrew a net $561M in Q2 2021, closing 579 positions and reducing 430 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $36.3M.

  • Prelude Capital Management's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 3,700,000 shares worth $36.3M.
  • Prelude Capital Management added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $19.4M increase.
  • Prelude Capital Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $7.72M.
  • Prelude Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2021, selling an estimated $39.4M.
  • Prelude Capital Management's ten largest holdings make up 31% of its $3.36B portfolio in Q2 2021.
  • Prelude Capital Management opened 694 new positions and closed 579 in Q2 2021.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $3.36B.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.